SCHEMBL17558558

SCHEMBL17558558

CCCc1c(C(=N)N)cccc1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.42
PLAU P00749 8/20 0.42
PLAT P00750 7/20 0.42
PRSS1 P07477 7/20 0.39
PRSS2 P07478 7/20 0.39
PRSS3 P35030 7/20 0.39
KLKB1 P03952 6/20 0.39
F7 P08709 5/20 0.39
F10 P00742 4/20 0.39
F9 P00740 1/20 0.39
LTB4R Q15722 1/20 0.37
LTB4R2 Q9NPC1 1/20 0.37
F2 P00734 3/20 0.37
HPN P05981 1/20 0.37
WDR5 P61964 1/20 0.37
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
HNF4A P41235 1/20 0.37
SYK P43405 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5476512 0.84 BCAT2 (0.59) BCAT2PLAUPLATLTB4RLTB4R2
SCHEMBL29137601 0.79 ALDH1A1 (0.45) LTB4RLTB4R2PDCD1CD274SMN1; SMN2
SCHEMBL15839774 0.76 PPARG (0.44) LTB4R2
SCHEMBL1034554 0.75 BCAT2 (0.63) BCAT2PLAUPLATPRSS1PRSS2
SCHEMBL32689453 0.75 BCAT2 (0.63) BCAT2PLAUPLATPRSS1PRSS2
SCHEMBL528810 0.75 BCL2L1 (0.52) LTB4RLTB4R2PDCD1CD274SMN1; SMN2
SCHEMBL1406272 0.75 ALDH1A1 (0.52) PDCD1CD274SMN1; SMN2
Ammonia Solution, Strong SCHEMBL29131061 0.74 BCAT2 (0.61) BCAT2PLAUPLATPRSS1PRSS2
Hydrochloric Acid SCHEMBL31621742 0.74 BCAT2 (0.61) BCAT2PLAUPLATPRSS1PRSS2
Hydrochloric Acid SCHEMBL27450056 0.74 BCAT2 (0.61) BCAT2PLAUPLATPRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3189026-A1 ESTROGEN RECEPTOR LIGAND TREATMENT FOR NEURODEGENERATIVE DISEASES The Regents of The University of California (US) 2017-07-12 EP disclosed
WO-2016036721-A1 ESTROGEN RECEPTOR LIGAND TREATMENT FOR NEURODEGENERATIVE DISEASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-03-10 WO disclosed